Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Yuko, Sakakibara"'
Autor:
Takahiro Amano, Takeo Yoshihara, Shinichiro Shinzaki, Yuko Sakakibara, Takuya Yamada, Naoto Osugi, Satoshi Hiyama, Yoko Murayama, Koji Nagaike, Hideharu Ogiyama, Toshio Yamaguchi, Yuki Arimoto, Ichizo Kobayashi, Shoichiro Kawai, Satoshi Egawa, Takashi Kizu, Masato Komori, Yuri Tsujii, Akiko Asakura, Taku Tashiro, Mizuki Tani, Yuriko Otake-Kasamoto, Ryotaro Uema, Minoru Kato, Yoshiki Tsujii, Takahiro Inoue, Tomomi Yamada, Tetsuhisa Kitamura, Atsushi Yonezawa, Hideki Iijima, Yoshito Hayashi, Tetsuo Takehara
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Serum leucine-rich alpha-2 glycoprotein (LRG) can monitor disease activities during biologics treatment in patients with inflammatory bowel disease (IBD). It is unclear whether the pretreatment serum LRG level can predict clinical effectiven
Externí odkaz:
https://doaj.org/article/2b96bcfc93bd4a9890869d07e766b71d
Autor:
Takahiro Amano, Shinichiro Shinzaki, Akiko Asakura, Taku Tashiro, Mizuki Tani, Yuriko Otake, Takeo Yoshihara, Shuko Iwatani, Takuya Yamada, Yuko Sakakibara, Naoto Osugi, Shuji Ishii, Satoshi Egawa, Manabu Araki, Yuki Arimoto, Masanori Nakahara, Yoko Murayama, Ichizo Kobayashi, Kazuo Kinoshita, Hiroyuki Ogawa, Satoshi Hiyama, Narihiro Shibukawa, Masato Komori, Yorihide Okuda, Takashi Kizu, Shunsuke Yoshii, Yoshiki Tsujii, Yoshito Hayashi, Takahiro Inoue, Hideki Iijima, Tetsuo Takehara
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract The outcomes of patients with elderly onset (EO) inflammatory bowel disease (IBD) treated with anti-tumor necrosis factor (TNF) remains uncertain. The present study evaluated the efficacy and safety of anti-TNF treatment for bio-naïve EO-IB
Externí odkaz:
https://doaj.org/article/a393ccddf9624fcf848e00d697103718
Autor:
Takahiro Amano, Hideki Iijima, Shinichiro Shinzaki, Taku Tashiro, Shuko Iwatani, Mizuki Tani, Yuriko Otake, Takeo Yoshihara, Aya Sugimoto, Satoshi Egawa, Shinjiro Yamaguchi, Kazuo Kinoshita, Manabu Araki, Motohiro Hirao, Yuko Sakakibara, Satoshi Hiyama, Hiroyuki Ogawa, Koji Nagaike, Jun Murata, Masato Komori, Yorihide Okuda, Takashi Kizu, Yoshiki Tsujii, Yoshito Hayashi, Takahiro Inoue, Hidekazu Takahashi, Tsunekazu Mizushima, Eiichi Morii, Tetsuo Takehara
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background The efficacy and safety of bevacizumab-containing chemotherapy for patients with metastatic duodenal and jejunal adenocarcinoma (mDJA) are unclear. The present study aimed to evaluate the efficacy of bevacizumab and to explore imm
Externí odkaz:
https://doaj.org/article/cf11e38281f34db5baa3f1fee1f8454b
Autor:
Takuya Yamada, Toshio Kuwai, Yoshihiro Sasaki, Yuko Sakakibara, Toshio Uraoka, Motohiko Kato, Noriko Watanabe, Toshihisa Kimura, Akiko Kada, Akiko M. Saito, Naohiko Harada
Publikováno v:
DEN Open, Vol 2, Iss 1, Pp n/a-n/a (2022)
Abstract Objectives This study aimed to evaluate the efficacy and safety of apixaban replacement (AR) as an alternative to heparin bridging (HB) in patients taking warfarin and scheduled for endoscopic mucosal resection (EMR) in the colorectum. Metho
Externí odkaz:
https://doaj.org/article/9fabcf3b17ed48319a7ceb38aea9a924
Autor:
Miyu Takahashi, Satoshi Tanaka, Shigen Kasakura, Wagu Watanabe, Satoshi Harada, Airi Miyazaki, Miho Kozuki, Masaki Kawabata, Hiroshi Tsumuro, Yuko Nishimura, Kensuke Matsushima, Yutaro Abe, Nobuyasu Fukutake, Hiroko Hasegawa, Shunsuke Yamamoto, Yuko Sakakibara, Shiro Yamamoto, Hisashi Ishida, Hiroshi Yamagami, Eiji Mita
Publikováno v:
Kanzo. 64:243-252
Autor:
Shinichiro Shinzaki, Toshimitsu Fujii, Shigeki Bamba, Maiko Ogawa, Taku Kobayashi, Masahide Oshita, Hiroki Tanaka, Keiji Ozeki, Sakuma Takahashi, Hiroki Kitamoto, Kazuhito Kani, Sohachi Nanjo, Takeshi Sugaya, Yuko Sakakibara, Toshihiro Inokuchi, Kazuki Kakimoto, Akihiro Yamada, Hisae Yasuhara, Yoko Yokoyama, Takuya Yoshino, Akira Matsui, Misaki Nakamura, Taku Tomizawa, Ryosuke Sakemi, Noriko Kamata, Toshifumi Hibi
Publikováno v:
Intestinal Research, Vol 16, Iss 4, Pp 609-618 (2018)
Background/Aims The influences of Helicobacter pylori eradication therapy on the disease course of inflammatory bowel disease (IBD) are still unclear. We therefore conducted a multicenter, retrospective cohort study to evaluate the safety of H. pylor
Externí odkaz:
https://doaj.org/article/3e886c3f695e421fb91d56212f82f76d
Autor:
Satoshi Harada1, Yuko Sakakibara1 yuko.sb@gmail.com, Hisashi Ishida1, Kiyoshi Mori2, Eiji Mita1
Publikováno v:
ACG Case Reports Journal. Jan2023, Vol. 10 Issue 1, p1-3. 3p.
Publikováno v:
American Journal of Gastroenterology.
Autor:
Yusuke Seiki, Satoshi Tanaka, Miyu Takahashi, Rei Higashiura, Masaki Kawabata, Gentaro Tanabe, Yuko Nishimura, Mao Miyoshi, Naoko Hayata, Tetsuro Miyazaki, Akio Ishihara, Nobuyasu Fukutake, Hiroko Hasegawa, Shunsuke Yamamoto, Yuko Sakakibara, Shoichi Nakazuru, Hisashi Ishida, Eiji Mita
Publikováno v:
Kanzo. 63:62-68
Autor:
Tomofumi Akasaka, Hiroko Hasegawa, Yuko Nishimura, Eiji Mita, Hiroshi Tsumuro, Hiroki Bessho, Akio Ishihara, Shoichi Nakazuru, Sena Higashi, Hisashi Ishida, Shunsuke Yamamoto, Yasuharu Kawamoto, Yuko Sakakibara, Satoshi Tanaka
Publikováno v:
Kanzo. 62:363-371